首次公开发行股票并上市
Search documents
双欣环保(001369) - 首次公开发行股票并在主板上市之上市公告书
2025-12-28 12:45
首次公开发行股票并在主板上市 内蒙古双欣环保材料股份有限公司 (鄂托克旗蒙西高新技术工业园) 股票简称:双欣环保 股票代码:001369 之 上市公告书 保荐人(主承销商) (北京市朝阳区建国门外大街 1 号国贸大厦 2 座 27 层及 28 层) 二〇二五年十二月 内蒙古双欣环保材料股份有限公司 上市公告书 特别提示 内蒙古双欣环保材料股份有限公司(以下简称"双欣环保""本公司""公 司"或"发行人")股票将于 2025 年 12 月 30 日在深圳证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素,在新 股上市初期切忌盲目跟风"炒新",应当审慎决策、理性投资。 如无特别说明,本上市公告书中的简称或名词的释义与《内蒙古双欣环保材 料股份有限公司首次公开发行股票并在主板上市招股说明书》(以下简称"招股 说明书")中的相同。 本上市公告书中若出现总计数与各分项数值之和尾数不符的情形,均为四舍 五入所致。 1 内蒙古双欣环保材料股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明与提示 本公司及全体董事、高级管理人员保证上市公告书的真实性、准确性、完整 性,承诺上市公告书 ...
元创股份(001325) - 首次公开发行股票并在主板上市之上市公告书
2025-12-16 12:34
股票简称:元创股份 股票代码:001325 元创科技股份有限公司 YACHOO TECHNOLOGY CO., LTD. (浙江省台州市三门县海润街道旗海路 55 号) 首次公开发行股票并在主板上市之 上市公告书 保荐人(主承销商) (中国(上海)自由贸易试验区商城路 618 号) 二〇二五年十二月 特别提示 元创科技股份有限公司(以下简称"元创股份"、"发行人"、"公司"、"本公 司")股票将于 2025 年 12 月 18 日在深圳证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素,在新 股上市初期切忌盲目跟风"炒新",应当审慎决策、理性投资。 如无特别说明,本上市公告书中的简称或名词的释义与本公司首次公开发行 股票并在主板上市招股说明书中的相同。如本上市公告书中合计数与各加数直接 相加之和在尾数上存在差异,系四舍五入所致。 本上市公告书"报告期"指:2022 年度、2023 年度、2024 年度、2025 年 1-6 月。 1 | 目录 | | --- | | 目录 2 | | --- | | 第一节 重要声明与提示 4 | | 一、重要声明 4 | | 二、主板新股上市 ...
汉诺医疗IPO辅导验收完成,中信证券保荐
Xin Lang Cai Jing· 2025-12-02 11:43
Core Points - The China Securities Regulatory Commission (CSRC) announced that CITIC Securities has submitted the completion report for the initial public offering (IPO) and listing guidance of Shenzhen Hanno Medical Technology Co., Ltd. The current status of Hanno Medical is "guidance acceptance" [1][25] - Hanno Medical, established in 2018 and located in Shenzhen, Guangdong Province, primarily engages in wholesale activities. The legal representative is Li Mingtang [1][25] - The controlling shareholder of Hanno Medical is Beijing Hanno Medical Technology Co., Ltd., which holds a 24.85% stake in the company [26] Financing History - Hanno Medical has undergone several financing rounds, including: - E+ round on June 21, 2024, raising nearly 100 million RMB [27] - E round on January 5, 2024, raising over 100 million RMB [28] - D round on February 23, 2023, with undisclosed financing [28] - C round on July 29, 2022, raising over 100 million RMB [28] - B round on February 15, 2022, with undisclosed financing [28] - A round on November 16, 2021, with undisclosed financing [28] - Angel round on October 27, 2020, with undisclosed financing [28] Company Governance Issues - During the reporting period, Hanno Medical established an internal governance structure and management system. However, with rapid business growth, there are areas for improvement in organizational management, operational capabilities, and risk control systems [3][39] - The intermediary institutions have assisted in enhancing governance by investigating and improving internal control systems and reviewing governance documents [4][30] Fundraising Project Issues - The guidance institution has worked with Hanno Medical to refine its fundraising project planning and ensure the smooth progress of fundraising projects, including feasibility report assessments [5][31] - Hanno Medical has cooperated with the guidance institution to conduct thorough research and discussions on the fundraising investment plan, confirming the specific uses and investment scale of the funds raised [6][32] Social Insurance and Housing Fund Issues - The guidance institution identified that Hanno Medical had not timely paid social insurance and housing funds for some employees during the reporting period [7][33] - Hanno Medical has taken steps to address these issues, including obtaining proof from administrative authorities that no penalties were imposed for these lapses [8][34]
上市临近!宇树科技完成辅导
Sou Hu Cai Jing· 2025-11-15 12:45
据证监会官网消息,宇树科技已发布IPO辅导工作完成报告。宇树科技拟申请在中国境内首次公开发行 股票并上市,中信证券开展辅导工作。 而据证监会网站10月21日发布的"辅导工作进展情况报告(第一期)"透露,辅导过程中,宇树科技召开 2025年第五次临时股东会,审议通过了《关于选举公司独立董事暨调整董事会成员的议案》《关于取消 公司监事会的议案》等议案。同时,鉴于原董事秦诗春、王其鑫、赵永政已先后在2025年第五次临时股 东会前辞任公司董事,接受辅导的人员不再包括公司原监事吴江、李文杨、朱嘉,以及原董事秦诗春、 王其鑫、赵永政等六人,并新增独立董事李宗彦、倪晨凯、宋华盛三人为接受辅导人员。 该报告同时透露,宇树科技2025年第五次临时股东会审议通过了《关于公司更名的议案》,决定公司更 名为"宇树科技股份有限公司"(之前为"杭州宇树科技股份有限公司")。 10月23日,天眼查App显示,宇树科技完成更名。同时,王兴兴由执行公司事务的董事变更为董事长。 辅导期内,中信证券和公司均认真履行了辅导协议的相关约定,勤勉尽责、诚实信用地开展了辅导工 作。中信证券作为公司的辅导机构,履行了相应职责使辅导计划得到了有效执行,公司管 ...
安闻科技启动IPO辅导
Xin Lang Cai Jing· 2025-11-05 01:13
证监会网站披露,安闻科技集团股份有限公司于2025年11月4日在河北证监局办理辅导备案登记,拟首 次公开发行股票并上市,辅导券商为广发证券。辅导备案报告显示,该公司控股股东张海涛,直接持有 公司股份比例为40.92%。 ...
马可波罗(001386) - 首次公开发行股票并在主板上市之上市公告书
2025-10-20 13:46
保荐人(主承销商) (深圳市福田区福田街道福华一路 111 号) 二〇二五年十月 股票简称:马可波罗 股票代码:001386 马可波罗控股股份有限公司 MarcoPolo Holdings Co., Ltd. (住所:广东省东莞市高埗镇北王路高埗段 102 号) 首次公开发行股票并在主板上市 之 上市公告书 特别提示 马可波罗控股股份有限公司(以下简称"马可波罗""公司""本公司" 或"发行人")股票将于 2025 年 10 月 22 日在深圳证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素,在 新股上市初期切忌盲目跟风"炒新",应当审慎决策、理性投资。 马可波罗控股股份有限公司 上市公告书 本上市公告书"报告期"指:2022 年度、2023 年度和 2024 年度。 1 如无特别说明,本上市公告书中的简称或名词的释义与本公司首次公开发 行股票并在主板上市招股说明书中的相同。如本上市公告书中合计数与各加数 直接相加之和在尾数上存在差异,系四舍五入所致。 | 六、发行方式及认购情况 33 | | --- | | (十一)未履行相关承诺事项的约束措施的承诺 67 | | --- ...
瑞立科密(001285) - 首次公开发行股票并在主板上市之上市公告书
2025-09-28 12:45
广州瑞立科密汽车电子股份有限公司 上市公告书 股票简称:瑞立科密 股票代码:001285 广州瑞立科密汽车电子股份有限公司 Guangzhou Ruili Kormee Automotive Electronic Co., Ltd. (广州经济技术开发区科学城南翔支路 1 号) 首次公开发行股票并在主板上市 之 上市公告书 保荐人(主承销商) (广东省深圳市福田区中心三路 8 号卓越时代广场(二期)北座) 二〇二五年九月 广州瑞立科密汽车电子股份有限公司 上市公告书 特别提示 广州瑞立科密汽车电子股份有限公司(以下简称"瑞立科密"、"公司"、"本公司" 或"发行人")股票将于 2025 年 9 月 30 日在深圳证券交易所上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素,在新股上市 初期切忌盲目跟风"炒新",应当审慎决策、理性投资。 如无特别说明,本上市公告书中的简称或名词释义与本公司首次公开发行股票招股 说明书中的相同。如本上市公告书中合计数与各加数直接相加之和在尾数上存在差异, 系由于四舍五入所致。 1 广州瑞立科密汽车电子股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明 ...
汉桑科技: 北京市君合律师事务所关于公司首次公开发行股票并在创业板上市的法律意见书
Zheng Quan Zhi Xing· 2025-08-04 16:47
Group 1 - The law firm JunHe has been appointed as the legal advisor for the initial public offering (IPO) of HANSAN (Nanjing) Technology Co., Ltd. and its listing on the Shenzhen Stock Exchange's Growth Enterprise Market [1][2] - The legal opinion confirms that the company has complied with relevant laws and regulations, including the Company Law and Securities Law, in its IPO process [4][5] - The company has received necessary approvals from the board of directors and shareholders for the IPO, with the board meeting held on May 18, 2023, and the annual general meeting on June 7, 2023 [5][6] Group 2 - HANSAN Technology is a joint-stock company established through the overall restructuring of HANSAN (Nanjing) Technology Co., Ltd., with a business license obtained on June 1, 2022 [7][8] - The company has been in continuous operation for over three years, meeting the requirements for the IPO [8] - The company has maintained a sound organizational structure, with no significant changes in its main business or management team in the past two years [12][13] Group 3 - The IPO involves the issuance of RMB ordinary shares (A shares) with a par value of RMB 1.00 per share, and the pricing will be determined based on market conditions [9][10] - The company has reported a net profit of RMB 253.65 million for the last fiscal year, with operating revenue not less than RMB 400 million, fulfilling the financial criteria for listing [15][16] - The company has engaged China International Capital Corporation as the sponsor for the IPO, ensuring compliance with regulatory requirements [17][18]
长宏股份启动IPO辅导近三年,主要产品发生变化
Sou Hu Cai Jing· 2025-07-30 07:26
Core Viewpoint - Changhong Technology Co., Ltd. is progressing with its IPO guidance work, having initiated the process in September 2022 and is expected to continue until June 2025 [1][5]. Group 1: Company Overview - Changhong Technology was established on May 20, 2010, with a registered capital of 29.5842 million yuan [2]. - The legal representative of the company is Dai Zhengliang, and the company primarily engages in the manufacturing of chemical raw materials and products [2]. - The controlling shareholders, Ye Xilai and Wen Xiaoying, hold a combined 72.57% of the company's shares through direct and indirect means [2]. Group 2: IPO Guidance Progress - The company has strengthened its internal control execution based on the guidance from Huazheng Securities, aligning its internal control systems with its operational conditions and key focus areas [5]. - The company is refining its business development goals and determining the direction of fundraising projects to ensure alignment with its future strategic development [5]. - There is an ongoing effort to standardize the accounting of R&D expenses, as the company has established a relatively complete R&D system but still needs to meet certain compliance and accounting standards for listing [6].
悍高集团(001221) - 首次公开发行股票并在主板上市之上市公告书
2025-07-28 12:46
股票简称:悍高集团 股票代码:001221 悍高集团股份有限公司 Higold Group Co., Ltd. (佛山市顺德区杏坛镇顺业东路 36 号之一) 首次公开发行股票并在主板上市 之 上市公告书 保荐人(主承销商) (中国(上海)自由贸易试验区商城路618号) 公告日期:2025 年 7 月 29 日 悍高集团股份有限公司 上市公告书 特别提示 悍高集团股份有限公司(以下简称"悍高集团"、"发行人"、"公司"或"本公 司")股票将于 2025 年 7 月 30 日在深圳证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素,在 新股上市初期切忌盲目跟风"炒新",应当审慎决策、理性投资。 如无特别说明,上市公告书中的简称或名词的释义与本公司首次公开发行 股票招股说明书中的相同。本上市公告书中若出现总计数与所列数值总和不符 的情形,均为四舍五入所致。 1 悍高集团股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明与提示 本公司及全体董事、监事、高级管理人员保证上市公告书的真实性、准确 性、完整性,承诺上市公告书不存在虚假记载、误导性陈述或者重大遗漏,并 依法承担法律 ...